Literature DB >> 11280370

In vitro evidence for effects of magnesium supplementation on quinolone-treated horse and dog chondrocytes.

M Egerbacher1, B Wolfesberger, C Gabler.   

Abstract

Quinolones and magnesium deficiency cause similar lesions in joint cartilage of young animals. Chondrocytes cultivated in the presence of quinolones and in Mg-free medium show severe alterations in cytoskeleton and decreased ability to adhere to the culture dish. We investigated whether Mg2+ supplementation can prevent quinolone-mediated effects on chondrocytes in vitro. Chondrocytes cultivated in Dulbecco's modified Eagle's medium/HAM's F-12 medium were treated with ciprofloxacin (80 and 160 microg/ml) and enrofloxacin (100 and 150 microg/ml). Mg2+ was added at a concentration of 0.0612 mg/ml (MgCl) and 0.0488 mg/ml (MgSO4) or a triple dose. In addition, cells were cultivated in Mg-free medium and accordingly treated with Mg2+ supplementation. After 5 days in culture, the number of adherent cells per milliliter was determined. The number of chondrocytes in quinolone-treated groups decreased to 12-36% that of the control group within the culture period. With Mg2+ supplementation, the number of attached cells increased to 40-70% that of control cells. The threefold dose of Mg2+ led to better results than did the single dose. Cell proliferation tested by immunohistochemical staining with Ki67 (clone MIB5) decreased from 70% in control groups to 55%, 48%, and 30% in enrofloxacin-treated groups in a concentration dependent manner (50, 100, and 150 microg/ml). Addition of Mg2+ did not increase the rate of cell proliferation. These results suggest that a great part of quinolone-induced damage is due to magnesium complex formation, as Mg2+ supplementation is able to reduce the effects in vitro. However, quinolone effects on cell proliferation seem to be an independent process that is not influenced by magnesium supplementation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11280370     DOI: 10.1354/vp.38-2-143

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  8 in total

1.  Diminished ciprofloxacin-induced chondrotoxicity by supplementation with magnesium and vitamin E in immature rats.

Authors:  Kerstin Pfister; Dago Mazur; Jürgen Vormann; Ralf Stahlmann
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

2.  In vitro assessment of human chondrocyte viability after treatment with local anaesthetic, magnesium sulphate or normal saline.

Authors:  J F Baker; P M Walsh; D P Byrne; K J Mulhall
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-02-18       Impact factor: 4.342

3.  A comparison of intra-articular magnesium and/or morphine with bupivacaine for postoperative analgesia after arthroscopic knee surgery.

Authors:  Sherif Farouk; Ansam Aly
Journal:  J Anesth       Date:  2009-11-18       Impact factor: 2.078

4.  Fluoroquinolone use in a child associated with development of osteochondritis dissecans.

Authors:  John C Jacobs; Kevin G Shea; Julia Thom Oxford; James L Carey
Journal:  BMJ Case Rep       Date:  2014-09-16

Review 5.  Ciprofloxacin safety in paediatrics: a systematic review.

Authors:  Abiodun Adefurin; Helen Sammons; Evelyne Jacqz-Aigrain; Imti Choonara
Journal:  Arch Dis Child       Date:  2011-07-23       Impact factor: 3.791

6.  Association between Dietary Magnesium Intake and Radiographic Knee Osteoarthritis.

Authors:  Chao Zeng; Hui Li; Jie Wei; Tuo Yang; Zhen-han Deng; Ye Yang; Yi Zhang; Tu-bao Yang; Guang-hua Lei
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

Review 7.  Analgesic effect and safety of single-dose intra-articular magnesium after arthroscopic surgery: a systematic review and meta-analysis.

Authors:  Chao Zeng; Yu-Sheng Li; Jie Wei; Dong-Xing Xie; Xi Xie; Liang-Jun Li; Shu-Guang Gao; Wei Luo; Yi-Lin Xiong; Wen-Feng Xiao; Guang-Hua Lei
Journal:  Sci Rep       Date:  2016-11-30       Impact factor: 4.379

Review 8.  Treatment of the Fluoroquinolone-Associated Disability: The Pathobiochemical Implications.

Authors:  Krzysztof Michalak; Aleksandra Sobolewska-Włodarczyk; Marcin Włodarczyk; Justyna Sobolewska; Piotr Woźniak; Bogusław Sobolewski
Journal:  Oxid Med Cell Longev       Date:  2017-09-25       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.